Cite
HARVARD Citation
Ladekarl, M. et al. (2022). Disparity in use of modern combination chemotherapy associated with facility type influences survival of 2655 patients with advanced pancreatic cancer. Acta oncologica. pp. 277-285. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ladekarl, M. et al. (2022). Disparity in use of modern combination chemotherapy associated with facility type influences survival of 2655 patients with advanced pancreatic cancer. Acta oncologica. pp. 277-285. [Online].